Inverness-based medical technology firm Aiber completes £2m fundraising round
Aiber, the trading name of MIME Technologies, offers first aid software with onboard kit, designed to support medical emergencies in environments remote from professional medical care. The technology was developed with input from two of the world’s leading airlines and is suitable for use on aircraft and ships.
Providing an end-to-end connection with medical services, it is specifically designed for use by non-medical professionals like cabin crew, allowing for more informed decisions about almost everything from burns and allergic reactions to potential heart complaints.
BGF, the UK and Ireland’s most active investor, has completed a £1.6m investment in Aiber. This completes a >£2m fundraising round, with existing investors Scottish Enterprise and Equity Gap also participating.
Anne Roberts, co-founder and chief executive of Aiber said: “As we continue to scale Aiber and its affordable one-touch technology, this investment will allow us to accelerate the roll out of our potentially life-saving solution to more customers in our target sectors. Whether in the air or at sea, a medical event in these situations can be incredibly stressful and isolating for those tasked with responding, and we are confident Aiber can reduce the burden and improve passenger health outcomes.”
The months ahead will be exciting! The funding will be used to support customers on a global scale. Our first aid software product with onboard kit was developed with input from two of the world’s leading airlines and is suitable for use on commercial airlines, business jets and onboard vessels. Providing an end-to-end connection with medical services, it is specifically designed for use by non-medical professionals like cabin crew, allowing for more informed decisions about a wide range of medical events from burns and allergic reactions to potential heart complaints.
Although improving medical outcomes in the sky alone has positive implications for both passenger wellbeing, safety and overall efficiency, many will also use Aiber to drive efficiencies, automating reporting for crew training, audit and litigation protection.
We are delighted to already have several high-profile trials underway in Europe and the US. Aiber’s huge potential and ability to align and support existing first aid training was further highlighted when the company participated in the prestigious ATI Boeing Accelerator Programme.
As well as providing direct investment, BGF’s Talent Network, the UK’s largest pool of non-executive directors, has introduced Tony Davis to the company. An aviation sector expert and former CEO of bmibaby and Tiger Airways, Davis has been appointed as a non-executive director.
Keith Barclay, BGF investor has commented: “We are pleased to complete this investment at an exciting moment of growth for Aiber. The company’s pioneering med-tech software product has a significant addressable market, and we look forward to supporting their push into new areas.”
Kerry Sharp, Director of Growth Investments at Scottish Enterprise, said: “Supporting innovative companies, like Aiber, to progress ground-breaking medical technology is a priority for Scottish Enterprise and we look forward to continuing our support as the company and its customers grow.”